Analyst consensus rating
Apnimed Analyst Rating: none
Direct answer
Apnimed's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $50.33.
Forecast evidence checked November 17, 2026.
Get free Apnimed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.28
- Average price target
- $50.33
- High price target
- $60.00
- Low price target
- $41.00
- Low target gap
- +151.8%
- Target upside
- +209.2%
- High target gap
- +268.6%
- Target range width
- 116.7%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- November 17, 2026
- Valid through
- November 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Apnimed?
Apnimed has a verified none consensus. The same dataset has an average price target of $50.33.
How far are Apnimed's low and high targets from the recorded price?
The low target implies +151.8%, while the high target implies +268.6%.
How many analysts are included in Apnimed's consensus?
The verified consensus includes 3 analysts.
How is Apnimed's target upside or downside calculated?
The average target of $50.33 is divided by the recorded price of $16.28, then one is subtracted to produce +209.2%. This does not guarantee a future return.
When was Apnimed's analyst forecast verified?
The data was verified on 2026-11-17. The dataset is valid through 2026-11-24.